U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07015918) titled 'A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men' on June 03.
Brief Summary: The purpose of this study is to learn about how much the study medicine PF-07976016 will be taken up and processed by healthy male participants. The total number of weeks of the study is up to approximately 12 weeks.
Study Start Date: June 04
Study Type: INTERVENTIONAL
Condition:
Healthy Male Volunteers
Intervention:
DRUG: [14C] PF-07976016
[14C] PF-07976016 liquid (oral) formulation
DRUG: PF-07976016
PF-07976016 liquid (oral) formulation
DRUG: [14C] PF-07976016
[14C] PF-07976016 intravenous (I...